Testing early HIV antibodies in infants to boost their health
Part of Infections clinical trials.
This trial tests whether giving a special neutralizing antibody (bNAb) early to infants living with HIV can help their immune system fight the virus better. It's for babies under 1 year old who are starting HIV treatment for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby must be between 1 day and 1 year old.
- Baby must have HIV-1 confirmed by a blood test.
- Baby must weigh more than 2.5 kilograms (about 5.5 pounds).
- Baby must not have had HIV treatment yet, or be on it for 30 days or less.
- Baby must be healthy enough to be cared for at home, with regular clinic visits.
- Parent or guardian must agree to the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving early neutralizing antibodies can help infants living with HIV control the virus better. It aims to improve their long-term health.
This trial tests a new antibody called BNT351 to see if it is safe and how it affects the immune system. It is for adults who either do not have HIV, or have HIV and are not currently on HIV medications.
This trial tests two lab-made antibodies that may help control HIV without daily pills. It is for people who started HIV treatment very early and now take a break from their regular meds under close monitoring.
This is an early-stage trial testing a new experimental drug (IAP-086-1) in people with HIV who have their virus well-controlled on current medications. Researchers want to understand how safe the drug is and how the body handles it.
This study tests whether giving a combination of two lab-made antibodies (PGT121.414.LS and VRC07-523LS) to newborns exposed to HIV during pregnancy is safe and how the body processes them. It may help protect infants from getting HIV after birth.
This study tests whether a combination of special antibodies (bNAbs) can help control HIV without daily medication. It involves several steps and is for children who are already doing well on ART.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.